This paper proposes publicly funding prescription drug trials as an alternative to the present system wherein pharmaceutical companies often finance and conduct tests of their drugs themselves. The report posits that in addition to substantial savings for the government, independent companies working under long-term federal contracts would result in full and accurate disclosure of the results of drug testing.
Download Info
To download:
If you experience problems downloading a file, check if you have the
proper application to
view it first. Information about this may be contained
in the File-Format links below. In case of further problems read
the IDEAS help
page. Note that these files are not on the IDEAS
site. Please be patient as the files may be large.
Publisher Info
Paper provided by Center for Economic and Policy Research (CEPR) in its series CEPR Reports and Issue Briefs with number
2008-09.
Length: 19 pages Date of creation: Mar 2008 Date of revision: Handle: RePEc:epo:papers:2008-09
Contact details of provider: Postal: 1611 Connecticut Ave, NW Suite 400, Washington, DC 20009 Phone: (202) 293-5380 Fax: (202) 588 1356 Email: Web page: http://www.cepr.net/ More information through EDIRC
For technical questions regarding this item, or to correct its listing, contact: ().
Find related papers by JEL classification: I - Health, Education, and Welfare I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health I12 - Health, Education, and Welfare - - Health - - - Health Production
This paper has been announced in the following NEP Reports:
References listed on IDEAS Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
repec:bep:evoice:4:2007:1:3 is not listed on IDEAS